TB-500, explained

Sold as though it were thymosin beta-4, TB-500 is a short fragment of it, and the distinction matters more than the label suggests. What it is, what the research shows, and what the marketing leaves out.

What it is and how it is supposed to work

Thymosin beta-4 is a 43-amino-acid protein involved in actin regulation, cell migration and wound repair, and it has been through genuine human trials as a topical and eye-drop formulation for corneal and skin wounds. TB-500 is not that. It is a short synthetic fragment, roughly seven amino acids, corresponding to the protein's actin-binding region.

The fragment was chosen because that region appears responsible for some of thymosin beta-4's cell-migration activity. Whether a fragment reproduces the behaviour of the whole protein is an empirical question, and for this one it has not been answered in humans.

What the research actually shows

For full-length thymosin beta-4 there are early-phase and phase 2 human trials in dry eye and corneal wound healing, with mixed results, plus preclinical cardiac work. For the fragment sold as TB-500 there are animal studies, largely in horses and rodents, on tendon and wound repair, and no human trials at all.

Risks, and what the marketing leaves out

Almost every efficacy claim made for TB-500 is sourced from the full-protein literature. Citing thymosin beta-4 trials to sell a thymosin beta-4 fragment is the same category of error as citing topical data to sell an injectable, and it is done consistently across the market.

No human safety data exists for the fragment. As with BPC-157, the mechanism itself, promoting cell migration and new blood-vessel growth, is the source of the main theoretical concern, and it has never been characterised in people. Its widest documented use is veterinary, particularly in racehorses, which is why it drew regulatory and anti-doping attention early and has been prohibited in sport for years.

Want the long version? Read the full TB-500 write-up, with sources.

Research use only. A reading aid for the published literature, not medical advice. Talk to a licensed prescriber before starting or stopping any medication.